Akura Medical

Akura Medical, a Shifamed Portfolio Company, specializes in developing advanced mechanical thrombectomy solutions aimed at efficiently removing large volume, mixed morphology clots. The company operates in the medical device market, focusing on vascular and pulmonary embolism treatments. Akura Medical primarily serves healthcare providers, including hospitals and specialized clinics, that require high-performance tools for clot removal procedures. The business model revolves around the research, development, and eventual commercialization of its proprietary thrombectomy platform. Revenue is generated through the sale of these medical devices once they receive regulatory approval, such as FDA clearance. Currently, the company is in the research and development phase and has secured $35M in Series B financing to expand clinical programs and scale manufacturing.

Keywords: thrombectomy, vascular, pulmonary embolism, medical device, clot removal, healthcare, FDA clearance, clinical programs, Series B financing, Shifamed.